NCT03524040View on ClinicalTrials.gov

Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Acne Vulgaris
Interventions
DEVICE

SEB-250

Gold microparticles (SEB-250) are massaged into 2 or 3 2x2 cm facial areas and exposed to 2 pulses from a diode laser

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen NV

All Listed Sponsors
collaborator

Sebacia, Inc.

INDUSTRY

lead

Merete Haedersdal

OTHER

NCT03524040 - Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography | Biotech Hunter | Biotech Hunter